Ryosuke Tanabe
Directeur/Membre du Conseil chez MITSUBISHI TANABE PHARMA CORPORATION
Profil
Ryosuke Tanabe is currently a Director at Mitsubishi Tanabe Pharma Corp.
He was previously a Director at NeuroDerm Ltd.
Postes actifs de Ryosuke Tanabe
| Sociétés | Poste | Début |
|---|---|---|
| MITSUBISHI TANABE PHARMA CORPORATION | Directeur/Membre du Conseil | - |
Anciens postes connus de Ryosuke Tanabe
| Sociétés | Poste | Fin |
|---|---|---|
| NEURODERM LTD | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |